1560 related articles for article (PubMed ID: 20217518)
41. β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis.
Lam CJ; Jacobson DR; Rankin MM; Cox AR; Kushner JA
J Clin Endocrinol Metab; 2017 Aug; 102(8):2647-2659. PubMed ID: 28323930
[TBL] [Abstract][Full Text] [Related]
42. A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes.
Rodriguez-Fernandez S; Almenara-Fuentes L; Perna-Barrull D; Barneda B; Vives-Pi M
Immunol Cell Biol; 2021 May; 99(5):461-474. PubMed ID: 33483995
[TBL] [Abstract][Full Text] [Related]
43. Bioprinting and Cellular Therapies for Type 1 Diabetes.
Ravnic DJ; Leberfinger AN; Ozbolat IT
Trends Biotechnol; 2017 Nov; 35(11):1025-1034. PubMed ID: 28789815
[TBL] [Abstract][Full Text] [Related]
44. The beta cell immunopeptidome.
Dudek NL; Purcell AW
Vitam Horm; 2014; 95():115-44. PubMed ID: 24559916
[TBL] [Abstract][Full Text] [Related]
45. Immunology of beta-cell destruction.
La Torre D; Lernmark A
Adv Exp Med Biol; 2010; 654():537-83. PubMed ID: 20217514
[TBL] [Abstract][Full Text] [Related]
46. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
[TBL] [Abstract][Full Text] [Related]
47. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
[TBL] [Abstract][Full Text] [Related]
48. Approaches for the cure of type 1 diabetes by cellular and gene therapy.
Jun HS; Yoon JW
Curr Gene Ther; 2005 Apr; 5(2):249-62. PubMed ID: 15853732
[TBL] [Abstract][Full Text] [Related]
49. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
50. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
51. Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".
Kent SC; Mannering SI; Michels AW; Babon JAB
Curr Diab Rep; 2017 Sep; 17(10):95. PubMed ID: 28864875
[TBL] [Abstract][Full Text] [Related]
52. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
53. Monitoring of beta cell replacement outcomes.
Chang CA; Haque WZ; Yoshimatsu G; Balajii PS; Lawrence MC; Naziruddin B
Panminerva Med; 2016 Mar; 58(1):59-71. PubMed ID: 26763742
[TBL] [Abstract][Full Text] [Related]
54. Tolerogenic strategies to halt or prevent type 1 diabetes.
Cooke A; Phillips JM; Parish NM
Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
[TBL] [Abstract][Full Text] [Related]
55. Real-time imaging of the pancreas during development of diabetes.
Martinic MM; von Herrath MG
Immunol Rev; 2008 Feb; 221():200-13. PubMed ID: 18275484
[TBL] [Abstract][Full Text] [Related]
56. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
57. Gene and cell therapies for diabetes mellitus: strategies and clinical potential.
Giannoukakis N; Robbins PD
BioDrugs; 2002; 16(3):149-73. PubMed ID: 12102644
[TBL] [Abstract][Full Text] [Related]
58. Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approach.
Longoni B; Mosca F
Curr Pharm Des; 2011; 17(29):3229-42. PubMed ID: 21864271
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus.
He B; Li X; Yu H; Zhou Z
J Diabetes; 2015 Nov; 7(6):762-73. PubMed ID: 25799887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
